Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-26-011718 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
77,000
Total Value
$0.00
P&L
+inf% (+$2,738,890.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Feb 23, 2026 | Grant/Award | 30,000 | $0.00 | $0.00 | 147,713 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 23, 2026 | Grant/Award | 47,000 | $0.00 | $0.00 | 47,000 | Direct | โ | View Details |